Sysmex (OTCMKTS:SSMXY) Sees Strong Trading Volume – What’s Next?

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) saw unusually-strong trading volume on Wednesday. 333,378 shares traded hands during mid-day trading, an increase of 74% from the previous session’s volume of 191,515 shares. The stock last traded at $11.88 and had previously closed at $11.91.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Check Out Our Latest Research Report on Sysmex

Sysmex Trading Up 0.2%

The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. The firm has a market cap of $7.51 billion, a price-to-earnings ratio of 28.41 and a beta of 1.18. The firm’s fifty day moving average is $11.70 and its 200-day moving average is $9.89.

Sysmex (OTCMKTS:SSMXY – Get Free Report) last posted its quarterly earnings data on Friday, August 7th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.02. The firm had revenue of $825.85 million during the quarter, compared to analyst estimates of $741.67 million. Sysmex had a return on equity of 8.01% and a net margin of 7.62%.Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. Equities analysts anticipate that Sysmex Corporation ADR will post 0.41 earnings per share for the current year.

Sysmex Company Profile

(Get Free Report)

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.

Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.

Recommended Stories

Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.